Meta Seeks Legal Shield From Child-Harm Lawsuits Amid KOSA Talks 
SpaceX Surpasses Amazon in Market Value as Post-IPO Rally Accelerates 
Hyundai to Acquire SoftBank’s Remaining Boston Dynamics Stake for $325 Million 
HSBC Australia Faces A$35M Penalty Over Scam Protection Failures 
Trump Says Anthropic No Longer Seen as National Security Threat 
Obayashi to Acquire Multiplex in $526M Expansion Deal 
Samsung Gains Interest from BYD, Google, AMD as AI Chip Demand Strains TSMC Capacity 
Google Gemini Co-Lead Noam Shazeer Leaves for OpenAI Amid AI Talent Race 
Carro Expands Into Australia With Acquisition of Used-Car Platform CarPlace 
Chinese Social Media Giant Xiaohongshu Eyes Hong Kong IPO at Over $70 Billion Valuation 
US Raises Concerns Over Possible ASML EUV Machine Transfer to China 
SoftBank Shares Drop as OpenAI Losses and Rising Costs Spark Investor Concerns 
Apple Signals Product Price Hikes Amid Rising Memory Chip Costs 
Qantas Nears Launch of World’s Longest Non-Stop Flights to London and New York 
TD Bank Expands Employee Monitoring Software to Boost Productivity Amid Privacy Concerns 
Kingboard Holdings Shares Surge After HK$11.77 Billion Block Trade to Expand PCB and AI Supply Chain Business 
BHP Shares Fall as Jansen Potash Project Costs Surge 
 - EconoTimes)
NEW YORK, Jan. 06, 2016 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL) in the United District Court for the Southern District of New York on behalf of a class consisting of all persons or entities who purchased securities between May 17, 2013 through December 28, 2015, inclusive (the “Class Period”). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).
The Complaint alleges Defendants issued materially false and misleading statements to investors and/or failed to disclose that: (1) Anavex had used a paid stock promoter to artificially inflate Anavex’s share price; and (2) as a result of the foregoing, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
If you wish to serve as lead plaintiff, you must move the Court no later than February 29, 2016. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, or to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq. or Gregory M. Egleston, Esq. of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected].
Please visit our website at http://www.gme-law.com for more information about the firm.
